Works by Reck, Martin

Results: 101
    1
    2
    3

    Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians.

    Published in:
    Respiration, 2022, v. 101, n. 3, p. 307, doi. 10.1159/000518896
    By:
    • Lommatzsch, Marek;
    • Rabe, Klaus F.;
    • Taube, Christian;
    • Joest, Marcus;
    • Kreuter, Michael;
    • Wirtz, Hubert;
    • Blum, Torsten Gerriet;
    • Kolditz, Martin;
    • Geerdes-Fenge, Hilte;
    • Otto-Knapp, Ralf;
    • Häcker, Brit;
    • Schaberg, Tom;
    • Ringshausen, Felix C.;
    • Vogelmeier, Claus F.;
    • Reinmuth, Niels;
    • Reck, Martin;
    • Gottlieb, Jens;
    • Konstantinides, Stavros;
    • Meyer, Joachim;
    • Worth, Heinrich
    Publication type:
    Article
    4

    MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage LIB-ILIB NSCLC.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 6, p. 587, doi. 10.1016/j.cllc.2024.06.007
    By:
    • Reck, Martin;
    • Nadal, Ernest;
    • Girard, Nicolas;
    • Filippi, Andrea R.;
    • Martin, Linda W.;
    • Gay, Carl M.;
    • Petersen, Cordula;
    • Gale, Davina;
    • Emeribe, Ugochinyere A.;
    • Georgoulia, Nefeli;
    • Perez, Ignacio E. Diaz;
    • Spicer, Jonathan D.
    Publication type:
    Article
    5

    STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non-Small Cell Lung Cancer With No Actionable Gene Alterations.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 3, p. 274, doi. 10.1016/j.cllc.2023.12.010
    By:
    • Rodriguez-Abreu, Delvys;
    • Bosch-Barrera, Joaquim;
    • Gray, Jhanelle E.;
    • Myung-Ju Ahn;
    • Johnson, Melissa;
    • Xinwei Yu;
    • Mohammad, Saad;
    • Xueying Chen;
    • Todd, Trever;
    • Jongseok Kim;
    • Reck, Martin
    Publication type:
    Article
    6
    7
    8

    Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.

    Published in:
    2018
    By:
    • Hirsch, Fred R.;
    • Kerr, Keith M.;
    • Bunn Jr, Paul A.;
    • Kim, Edward S.;
    • Obasaju, Coleman;
    • Pérol, Maurice;
    • Bonomi, Philip;
    • Bradley, Jeffrey D.;
    • Gandara, David;
    • Jett, James R.;
    • Langer, Corey J.;
    • Natale, Ronald B.;
    • Novello, Silvia;
    • Paz-Ares, Luis;
    • Ramalingam, Suresh S.;
    • Reck, Martin;
    • Reynolds, Craig H.;
    • Smit, Egbert F.;
    • Socinski, Mark A.;
    • Spigel, David R.
    Publication type:
    journal article
    9

    Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial.

    Published in:
    2018
    By:
    • Ramalingam, Suresh S.;
    • Pérol, Maurice;
    • Reck, Martin;
    • Kowalyszyn, Ruben Dario;
    • Gautschi, Oliver;
    • Kimmich, Martin;
    • Eun Kyung Cho;
    • Czyzewicz, Grzegorz;
    • Grigorescu, Alexandru;
    • Karaseva, Nina;
    • Dakhil, Shaker;
    • Pablo Lee;
    • Zimmerman, Annamaria;
    • Sashegyi, Andreas;
    • Alexandris, Ekaterine;
    • Carter, Gebra Cuyun;
    • Winfree, Katherine B.;
    • Garon, Edward B.;
    • Cho, Eun Kyung;
    • Lee, Pablo
    Publication type:
    journal article
    10
    11
    12
    13

    Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation- Positive Metastatic Non—Small-Cell Lung Cancer.

    Published in:
    2017
    By:
    • Garon, Edward B.;
    • Reck, Martin;
    • Paz-Ares, Luis;
    • Ponce, Santiago;
    • Jaime, Jesus Corral;
    • Juan, Oscar;
    • Nadal, Ernest;
    • Lee, Pablo;
    • Dalai, Rita;
    • Jingyi Liu;
    • Shuang He;
    • Treat, Joseph;
    • Kazuhiko Nakagawa;
    • Dalal, Rita;
    • Liu, Jingyi;
    • He, Shuang;
    • Nakagawa, Kazuhiko
    Publication type:
    journal article
    14
    15
    16
    17
    18

    Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non--Small-Cell Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2014, v. 15, n. 3, p. 188, doi. 10.1016/j.cllc.2013.12.005
    By:
    • von Pawel, Joachim;
    • Harvey, Jimmie H.;
    • Spigel, David R.;
    • Dediu, Mircea;
    • Reck, Martin;
    • Cebotaru, Cristina L.;
    • Humphreys, Robin C.;
    • Gribbin, Matthew J.;
    • Fox, Norma Lynn;
    • Camidge, D. Ross
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma.

    Published in:
    Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 251, doi. 10.1007/s00262-021-02981-w
    By:
    • Budczies, Jan;
    • Kirchner, Martina;
    • Kluck, Klaus;
    • Kazdal, Daniel;
    • Glade, Julia;
    • Allgäuer, Michael;
    • Kriegsmann, Mark;
    • Heußel, Claus-Peter;
    • Herth, Felix J.;
    • Winter, Hauke;
    • Meister, Michael;
    • Muley, Thomas;
    • Goldmann, Torsten;
    • Fröhling, Stefan;
    • Wermke, Martin;
    • Waller, Cornelius F.;
    • Tufman, Amanda;
    • Reck, Martin;
    • Peters, Solange;
    • Schirmacher, Peter
    Publication type:
    Article
    28

    A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 799, doi. 10.1007/s00262-019-02315-x
    By:
    • Sebastian, Martin;
    • Schröder, Andreas;
    • Scheel, Birgit;
    • Hong, Henoch S.;
    • Muth, Anke;
    • von Boehmer, Lotta;
    • Zippelius, Alfred;
    • Mayer, Frank;
    • Reck, Martin;
    • Atanackovic, Djordje;
    • Thomas, Michael;
    • Schneller, Folker;
    • Stöhlmacher, Jan;
    • Bernhard, Helga;
    • Gröschel, Andreas;
    • Lander, Thomas;
    • Probst, Jochen;
    • Strack, Tanja;
    • Wiegand, Volker;
    • Gnad-Vogt, Ulrike
    Publication type:
    Article
    29
    30
    31

    In Reply.

    Published in:
    Deutsches Ärzteblatt International, 2023, v. 120, n. 41, p. 3, doi. 10.3238/arztebl.m2023.0198
    By:
    • Reck, Martin;
    • Vogel-Claussen, Jens
    Publication type:
    Article
    32

    Lung Cancer Screening With Low-Dose Computed Tomography.

    Published in:
    Deutsches Ärzteblatt International, 2023, v. 120, n. 23, p. 387, doi. 10.3238/arztebl.m2023.0099
    By:
    • Reck, Martin;
    • Dettmer, Sabine;
    • Kauczor, Hans-Ulrich;
    • Kaaks, Rudolf;
    • Reinmuth, Niels;
    • Vogel-Claussen, Jens
    Publication type:
    Article
    33

    Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non-small cell lung cancer.

    Published in:
    Cancer (0008543X), 2015, v. 121, n. 6, p. 883, doi. 10.1002/cncr.29132
    By:
    • Doebele, Robert C.;
    • Spigel, David;
    • Tehfe, Mustapha;
    • Thomas, Sachdev;
    • Reck, Martin;
    • Verma, Sunil;
    • Eakle, Janice;
    • Bustin, Frederique;
    • Goldschmidt, Jerome;
    • Cao, Dachuang;
    • Alexandris, Ekaterine;
    • Yurasov, Sergey;
    • Camidge, D. Ross;
    • Bonomi, Philip
    Publication type:
    Article
    34
    35

    Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR-Expressing Squamous Non-Small-Cell Lung Cancer: German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE).

    Published in:
    Oncology Research & Treatment, 2016, v. 39, n. 9, p. 539, doi. 10.1159/000448085
    By:
    • Reck, Martin;
    • Thomas, Michael;
    • Kropf-Sanchen, Cornelia;
    • Mezger, Jörg;
    • Socinski, Mark A.;
    • Depenbrock, Henrik;
    • Soldatenkova, Victoria;
    • Brown, Jacqueline;
    • Krause, Thomas;
    • Thatcher, Nick
    Publication type:
    Article
    36

    Immunotherapy for Lung Cancer.

    Published in:
    Oncology Research & Treatment, 2016, v. 39, n. 6, p. 360, doi. 10.1159/000446726
    By:
    • Reinmuth, Niels;
    • Reck, Martin
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43

    Immuntherapie bei Lungenkrebs.

    Published in:
    Kompass Onkologie, 2016, v. 3, n. 2, p. 60, doi. 10.1159/000449440
    By:
    • Reinmuth, Niels;
    • Reck, Martin
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50